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Abstract 
	  
    A relatively simple, rapid, economic and accessible method based on ultra high performance liquid 
chromatography coupled with a diode array detector (UHPLC-DAD) was developed for the analysis and 
simultaneous determination of five ginsenosides (Rg1, Re, Rf, Rc, Rd) in Panax Ginseng Radix et Rhizoma 
Rubra (Red Ginseng), a traditional Chinese medicinal plant. Sonication and solid phase extraction (SPE) were 
applied to the sample preparation and the chromatography was performed on Agilent Bonus- FP C18 column 
involving a gradient elution with acetonitrile/water as the mobile phase. The amounts of the five ginsenosides 
were determined on the basis of external standard method (ESM). The method validation was performed 
according to the method performance requirements, inclusive of precision, recovery, specificity, stability, 
linearity and robustness. Due to the results obtained the developed method is expected to provide a reliable 
basis for the quality assessment of red ginseng products.   
 
Keywords: ginsenosides, Panax Ginseng Radix et Rhizoma Rubra, quantitative determination, solid phase 
extraction, ultra high performance liquid chromatography 
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1. Introduction 
	  
    The steamed and dried root of Panax Ginseng Radix et Rhizoma Rubra (Red Ginseng) represents a highly 
esteemed traditional medicine in Eastern Asia and has been used over the last centuries as a protection against 
numerous diseases, providing myriads of beneficial pharmacological effects on central nerve, cardiovascular, 
endocrine and immune system [1-12]. In addition ginseng and its constituents have been ascribed 
antineoplastic and immunmodulatory activity, reported in numerous studies [1,2,4,5,8,9,12,13]. Red Ginseng is 
generated from white ginseng (Panax Ginseng Radix et Rhizoma) through an additional steaming step at 95-
100°C for 2-3 hours, followed by drying [8,10]. Particularly valued as a tonic and regarded as a health food it 
is used as a dietary supplement, taken orally after decoction [1,2,6,7]. There exists extensive literature pointing 
out that most of the beneficial effects of ginseng are attributed to the ginsenosides, major active components, 
which represent steroidal saponins [2-5,7,9,13]. A high number of ginsenosides have been isolated and 
characterized, showing different pharmacological effects. Due to the nature of the steroid skeleton steroids 
possess numerous physiological activities. Considered as lipid soluble signaling molecules, steroids can 
intercalate into the plasma membran and initiate genomic effects. Ginsenosides depict a structural variety, 
differing by the number and site of attachment, the type of sugar moieties and the stereochemistry at C-20 [5]. 
Based on their aglycone moieties, ginsenosides can be divided into 20 (S)- protopanaxadiol and 20 (S)- 
protopanaxatriol [2,5,7,9], shown in the Figure I-1 below [2]:  
 
Figure I-1 Structure of the major ginsenosides in Panax ginseng. Glc: glucose, Rha: rhamnose, Ara: arabinose.  
 
 
 
  
 
 
 
	  
Ginsenoside	   R₁	   R₂	  
Rg1	   Glc	   Glc	  
Re	   Glc²-­‐Rha	   Glc	  
Rf	   Glc²-­‐Glc	   H	  
	  
	  
Ginsenoside	   R₁	   R₂	  
Rc	   Glc²-­‐Glc	   Glc⁶-­‐Ara(f)	  
Rd	   Glc²-­‐Glc	   Glc	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    Numerous investigations on the determination and quantification of multiple ginsenosides in various types 
of ginseng samples have been performed, occasionally with the aim to establish a reliable quality control [2,7-
14]. Many methods have been developed, including thin layer chromatography (TLC), high-performance 
liquid chromatography (HPLC) coupled with an ultraviolet (UV) detector, evaporative light scattering detector 
(ELSD), pulsed amperometric detector (PAD), charged aerosol detector (CAD), enzyme linked 
immunosorbent assay (ELISA) and mass spectrometry (MS) [2,8-9,15]. However, ginsenosides could not be 
fully separated due to their very similar structures with the result that the amount of each ginsenoside could not 
be determined precisely [2]. High-performance liquid chromatography (HPLC) coupled with various detectors 
is the most commonly employed analytical method for the detection of ginsenosides. Unfortunately, in order to 
acquire a quantitative analysis for the ginsenosides by traditional HPLC, one or more hours per sample run are 
generally required, which results in a long analysis time and a high solvent consumption [13]. In the field of 
chromatographic analysis, the identification and quantification of components of traditional Chinese medicines 
(TCM) are the main challenges for high-performance liquid chromatography (HPLC). As a result ultra-
performance liquid chromatography (UPLC), has recently been applied as an alternative showing not only 
advantages, such as a faster analysis without reducing separation efficiency, but also advancements regarding 
speed, resolution, and sensitivity [12-14]. 
 
    In the present study a UHPLC- DAD method was developed for the simultaneous determination of five 
ginsenosides (Rg1, Re, Rf, Rc, Rd) in Panax Ginseng Radix et Rhizoma Rubra. Among the ginsenosides 
contained in Red Ginseng, the five ginsenosides represent the major components due to their relatively high 
content. Besides the improvements in terms of expenses, a more efficient separation of target peaks, resulting 
in a greater resolution, higher peak capacity and better baseline separation, could be attained.  Furthermore the 
number of reference standards, necessary for the determination of material, was easy to obtain. A great 
reduction regarding the duration of analysis could be achieved by the use of UHPLC, with the result of a lower 
consumption of solvent. Performing with UHPLC demands higher requirements concerning the sample 
solution compared to the use of the conventional HPLC. The most decisive outcome of this study was the 
purification of the sample solution due to the use of SPE column, involved in the sample preparation. The 
result of which is a secure assessment of stable results and a protection of the applied column, which would be 
damaged by the viscosity of the sample solution due to the impurities contained in it. Based on the study above 
a relatively simple, rapid, economic and accessible method could be established.  
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2. Experimental 
 
2.1 Chemicals and standards 
	  
    Acetonitrile (UV grade, LOT CZ448) was purchased from Honeywell (USA). Phosphoric acid (85%, HPLC 
grade, PS1434-002) was obtained from Tedia (USA). Methanol (AR grade, LOT T20111214) was purchased 
from Sinopharm Chemical Reagent Co. Ltd. (China). Five Ginsenosides, namely Ginsenoside Rg1 (Rg1), 
Ginsenoside Re (Re), Ginsenoside Rf (Rf), Ginsenoside Rc (Rc) and Ginsenoside Rd (Rd) were bought from 
National Institute for Control of Biological and Pharmaceutical Products of China with the purity of 96.3% for 
Rg1, 89.1% for Re, 98% for Rf and Rc and 94.4% for Rd. All other reagents and solvents were of either 
analytical or HPLC grade.  
 
2.2 Material 
	  
    Four batches of Panax Ginseng Radix et Rhizoma Rubra were collected from major herbal distribution 
centers in China, including No.1-3 (Fusong) and No.4 (Ji-an). All samples were identified by Professor De-an 
Guo (Shanghai Institute of Materia Medica, Chinese Academy of Sciences). Illustrations are shown below. 
 
	  
Red	  Ginseng	  Batch	  Nr.	  1	  
	  
Red	  Ginseng	  Batch	  Nr.	  2	  
	  
Red	  Ginseng	  Batch	  Nr.	  3	  
	  
Red	  Ginseng	  Batch	  Nr.	  4	  
 
2.3 Apparatus 
	  
    UHPLC separation was performed on an Agilent 1290 Infinity Ultra High Performance LC system (Agilent 
Technologies Palo Alto CA, USA), comprising a binary solvent manager (G4220 A), a sample manager 
(G4226A), a temperature controller (G1316C), a DAD detector (G4212A) and ChemStation for LC3D-systems 
(Rev.B.04.03[54]). Sonication was performed on BRANSON B3500S-DTH sonication bath (BRANSON Co. 
Ltd., Shanghai, China). Standards were weighted using Sartorius BT125D electronic balance (Sartorius 
mechatronics, Beijing). Samples were weighted using Sartorius CPA224S electronic balance (Sartorius 
mechatronics, Beijing). 
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3. Method, results and discussion 
3.1. Investigation of the sample preparation 
	  
Optimized sample preparation method: 
    Transfer about 0.4 g of Red Ginseng powder, accurately weighed, to a 50-mL centrifuge tube. Add 20 mL of 
70% aqueous solution of methanol. Attach a plug, in order to avoid the evaporation of methanol. Sonicate for 
15 min, then centrifuge at 4000 r/min for 10 min. Transfer the supernatant to a 50-mL volumetric flask. Add 
another 20 mL of solvent to the test tube and repeat the mentioned procedure with 15 min of sonication time. 
Dilute with extraction solvent to volume. Shake well and pass through a filter having 0.45-µm porosity, 
discard about 1 mL of the first part of the filtrate. Transfer 6 mL of the subsequent filtrate to a flask and add 
respective volume of water in order to obtain a mixture containing 20% methanol. Sonicate for 10 min to mix 
well.  
Condition the solid- phase extraction column containing C18 packaging with a sorbent mass to column volume 
ratio of 200mg/4mL, before solvent application by washing the column with 3 mL 100% methanol and 5 mL 
pure water. Do not allow the column to dry.  
Transfer the sample solution to the SPE column and elute at the rate of 1 drop/s. Then wash the flask and the 
residue 3 times with 2 mL 20% aqueous solution of methanol and pass it trough the column. Subsequently 
perform a wash of the column with 3 mL pure water, discard the filtrate. Then elute the column with methanol 
and collect the eluent into a 2-mL volumetric flask, then shake well and pass through a filter having 0.22-µm 
porosity prior to use, discard about 0.5 mL of the first part of the filtrate.  
   
 
Chromatographic system: 
Solution A: water 
Solution B: filtered and degassed acetonitrile  
Standard solution: 0.0572mg/mL of Rg1, 0.0353 mg/mL of Re, 0.0222mg/mL of Rf, 0.0531mg/mL of Rc, 
0.0247 mg/mL of Rd 
Column: Agilent Bonus- FP C18 (2.1×100mm, 1.8µm; Part No. 828768-901; Serial No. USCCZ01170); 
Agilent 1290 Infinity In-Line Filter 
Mobile phase: See the gradient below. 
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Time 
(minutes) 
A 
(%) 
B 
(%) 
0 82 18 
5 78 22 
7 72 28 
15 56 44 
23 0 100 
32 0 100 
Detector: UV, 203 nm 
Flow rate: 0.45 mL/min 
Injection size: 5 µL 
Column temperature: 40 °C 
Integration parameters: Slope sensitivity: 5; Peak width: 0.02; Baseline at Valleys 
Alcohol: 70% methanol (CH₃OH, v/v) 
 
Abbreviation:  
Rg1: Ginsenoside Rg1 
Re: Ginsenoside Re 
Rf: Ginsenoside Rf 
Rc: Ginsenoside Rc 
Rd: Ginsenoside Rd 
 
3.1.1 Method for extraction 
	  
3.1.1.1 Extraction solvent 
    The samples were prepared in duplicates using three different solvent proportions, inclusive of 60% aqueous 
solution of methanol, 70% aqueous solution of methanol and 80% aqueous solution of methanol as shown in 
Table I-3-1-1-1.  
   Perform as follows: 
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   Transfer about 0.4 g of Red Ginseng powder, accurately weighed, to a 50-mL centrifuge tube. Add 20 mL of 
different solvent, respectively. Attach a plug, in order to avoid the evaporation of methanol. Sonicate for 30 
min, then centrifuge at 4000 r/min for 10 min. Transfer the supernatant to a 50-mL volumetric flask. Add 
another 20 mL of solvent to the centrifuge tube and repeat the mentioned procedure with 15 min of sonication 
time. Dilute with extraction solvent to volume. Shake well and pass through a filter having 0.45-µm porosity, 
discard about 1 mL of the first part of the filtrate. Transfer 6 mL of the subsequent filtrate to a flask and add 
respective volume of water in order to obtain a mixture containing 20% methanol. Sonicate for 10 min to mix 
well.  
Condition the solid- phase extraction column containing C18 packaging with a sorbent mass to column volume 
ratio of 200mg/4mL, before solvent application by washing the column with 3 mL 100% methanol and 5 mL 
pure water. Do not allow the column to dry.  
Transfer the sample solution to the SPE column and elute at the rate of 1 drop/s. Then wash the flask and the 
residue 3 times with 2 mL 20% aqueous solution of methanol and pass it trough the column. Subsequently 
perform a wash of the column with 3 mL pure water, discard the filtrate. Then elute the column with methanol 
and collect the eluent into a 2-mL volumetric flask, then shake well and pass through a filter having 0.22-µm 
porosity prior to use, discard about 0.5 mL of the first part of the filtrate.  
    Separately inject equal volumes (5 µL) of these prepared sample solutions into the UHPLC chromatograph, 
record the chromatogram and calculate the content (Table I-3-1-1-1).   
 
Table I-3-1-1-1 Selection of extraction solvent (n=2) 
Extraction 
solvent 
proportion 
Rg1 
(%) 
Re 
(%) 
Rf 
(%) 
Rc 
(%) 
Rd 
(%) 
Sum 
(%) 
60% 0.252 0.143 0.108 0.171 0.093 0.766 
70% 0.256 0.139 0.114 0.095 0.173 0.776 
80% 0.254 0.138 0.112 0.094 0.170 0.769 
      
    According to the results the highest extraction efficiency was obtained with 70% aqueous solution of 
methanol, thus 70% aqueous solution of methanol was selected for further investigations.  
 
3.1.1.2 Extraction solvent volume 
    The experiment investigated the volume of solvent (35 mL, 40 mL and 45 mL).  
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Perform as follows: 
    Transfer about 0.4 g of Red Ginseng powder, accurately weighed, to a 50-mL centrifuge tube. Add 15, 20, 
20 mL of 70% aqueous solution of methanol. Attach a plug, in order to avoid the evaporation of methanol. 
Sonicate for 30 min, then centrifuge at 4000 r/min for 10 min. Transfer the supernatant to a 50-mL volumetric 
flask. Add another 20, 20, 25 mL of solvent to the centrifuge tube and repeat the mentioned procedure with 15 
min of sonication time. Dilute with extraction solvent to volume. Shake well and pass through a filter having 
0.45-µm porosity, discard about 1 mL of the first part of the filtrate. Transfer 6 mL of the subsequent filtrate to 
a flask and add respective volume of water in order to obtain a mixture containing 20% methanol. Sonicate for 
10 min to mix well.  
Condition the solid- phase extraction column containing C18 packaging with a sorbent mass to column volume 
ratio of 200mg/4mL, before solvent application by washing the column with 3 mL 100% methanol and 5 mL 
pure water. Do not allow the column to dry.  
Transfer the sample solution to the SPE column and elute at the rate of 1 drop/s. Then wash the flask and the 
residue 3 times with 2 mL 20% aqueous solution of methanol and pass it trough the column. Subsequently 
perform a wash of the column with 3 mL pure water, discard the filtrate. Then elute the column with methanol 
and collect the eluent into a 2-mL volumetric flask, then shake well and pass through a filter having 0.22-µm 
porosity prior to use, discard about 0.5 mL of the first part of the filtrate.  
    Separately inject equal volumes (5 µL) of these prepared sample solutions into the UHPLC chromatograph, 
record the chromatogram and calculate the content (Table II-3-1-1-2).   
 
Table II-3-1-1-2 Selection of solvent volume (n=2) 
Extraction 
solvent 
volume 
Rg1 
(%) 
Re 
(%) 
Rf 
(%) 
Rc 
(%) 
Rd 
(%) 
Sum 
(%) 
15+20 mL 0.251 0.137 0.111 0.093 0.172 0.764 
20+20 mL 0.250 0.138 0.112 0.094 0.170 0.764 
20+25 mL 0.241 0.134 0.109 0.091 0.166 0.740 
 
    With regard to the extraction efficiency the highest values were achieved with a solvent volume of 35 mL as 
well as 40 mL. Due to a necessary dilution to 50 mL within the sample preparation, 40 mL was selected as 
extraction solvent, in order to secure a high assessment of extraction without a waste of solvent. Owing to that 
fact it was chosen for further investigations.  
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3.1.1.3 Extraction frequency 
    The experiment investigated the frequency of extraction (once, twice or thrice).  
Perform as follows: 
    Transfer about 0.4 g of Red Ginseng powder, accurately weighed, to a 50-mL centrifuge tube. 
 
Once: Add 40 mL of 70% aqueous solution of methanol. Attach a plug, in order to avoid the evaporation of 
methanol. Sonicate for 45 min, then centrifuge at 4000 r/min for 10 min. Transfer the supernatant to a 50-mL 
volumetric flask.  
Twice: Add 20 mL of 70% aqueous solution of methanol. Attach a plug, in order to avoid the evaporation of 
methanol. Sonicate for 30 min, then centrifuge at 4000 r/min for 10 min. Transfer the supernatant to a 50-mL 
volumetric flask. Add another 20 mL of solvent to the centrifuge tube and repeat the mentioned procedure with 
15 min of sonication time. 
Thrice: Add 20 mL of 70% aqueous solution of methanol. Attach a plug, in order to avoid the evaporation of 
methanol. Sonicate for 15 min, then centrifuge at 4000 r/min for 10 min. Transfer the supernatant to a 50-mL 
volumetric flask. Add another 10 mL of solvent to the centrifuge tube and repeat the mentioned procedure with 
15 min of sonication time. Perform the extraction with 10 mL solvent twice, as directed in the precedent step. 
 
    Dilute with extraction solvent to volume. Shake well and pass through a filter having 0.45-µm porosity, 
discard about 1 mL of the first part of the filtrate. Transfer 6 mL of the subsequent filtrate to a flask and add 
respective volume of water in order to obtain a mixture containing 20% methanol. Sonicate for 10 min to mix 
well.  
Condition the solid- phase extraction column containing C18 packaging with a sorbent mass to column volume 
ratio of 200mg/4mL, before solvent application by washing the column with 3 mL 100% methanol and 5 mL 
pure water. Do not allow the column to dry.  
Transfer the sample solution to the SPE column and elute at the rate of 1 drop/s. Then wash the flask and the 
residue 3 times with 2 mL 20% aqueous solution of methanol and pass it trough the column. Subsequently 
perform a wash of the column with 3 mL pure water, discard the filtrate. Then elute the column with methanol 
and collect the eluent into a 2-mL volumetric flask, then shake well and pass through a filter having 0.22-µm 
porosity prior to use, discard about 0.5 mL of the first part of the filtrate.  
    Separately inject equal volumes (5 µL) of these prepared sample solutions into the UHPLC chromatograph, 
record the chromatogram, measure the peak area and calculate the content (Table III- 3-1-1-3).   
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Table III-3-1-1-3 Selection of extraction frequency (n=2) 
Extraction 
frequency 
Rg1 
(%) 
Re 
(%) 
Rf 
(%) 
Rc 
(%) 
Rd 
(%) 
Sum 
(%) 
45 min 0.242 0.134 0.110 0.092 0.174 0.753 
30+15 min 0.249 0.134 0.113 0.095 0.181 0.772 
15+15+15 min 0.250 0.134 0.113 0.095 0.111 0.774 
 
    In consideration of convenience and efficiency, sonication twice was chosen.  
 
3.1.1.4 Time- length of extraction 
    The experiment investigated the extraction time (15+15 minutes, 30+15 minutes and 45+15 minutes).   
Perform as follows: 
    Transfer about 0.4 g of Red Ginseng powder, accurately weighed, to a 50 mL centrifuge tube. Add 20 mL of 
70% aqueous solution of methanol. Attach a plug, in order to avoid the evaporation of methanol. Sonicate for 
15, 30, 45 min, then centrifuge at 4000 r/min for 10 min. Transfer the supernatant to a 50-mL volumetric flask. 
Add another 20 mL of solvent to the centrifuge tube and repeat the mentioned procedure with 15 min of 
sonication time. Dilute with extraction solvent to volume. Shake well and pass through a filter having 0.45-µm 
porosity, discard about 1 mL of the first part of the filtrate. Transfer 6 mL of the subsequent filtrate to a flask 
and add respective volume of water in order to obtain a mixture containing 20% methanol. Sonicate for 10 min 
to mix well.  
Condition the solid- phase extraction column containing C18 packaging with a sorbent mass to column volume 
ratio of 200mg/4mL, before solvent application by washing the column with 3 mL 100% methanol and 5 mL 
pure water. Do not allow the column to dry.  
Transfer the sample solution to the SPE column and elute at the rate of 1 drop/s. Then wash the flask and the 
residue 3 times with 2 mL 20% aqueous solution of methanol and pass it trough the column. Subsequently 
perform a wash of the column with 3 mL pure water, discard the filtrate. Then elute the column with methanol 
and collect the eluent into a 2-mL volumetric flask, then shake well and pass through a filter having 0.22-µm 
porosity prior to use, discard about 0.5 mL of the first part of the filtrate.  
    Separately inject equal volumes (5 µL) of these prepared sample solutions into the UHPLC chromatograph, 
record the chromatogram and calculate the content (Table IV-3-1-1-4).   
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Table IV-3-1-1-4 Selection of Time- length of extraction (n=2) 
Extraction 
time 
Rg1 
(%) 
Re 
(%) 
Rf 
(%) 
Rc 
(%) 
Rd 
(%) 
Sum 
(%) 
15+15 min 0.252 0.137 0.113 0.095 0.180 0.777 
30+15 min 0.249 0.134 0.113 0.095 0.181 0.772 
45+15 min 0.246 0.133 0.113 0.094 0.178 0.765 
 
    According to the results the highest content amount of the target compounds was obtained with an extraction 
time of 15+15 minutes. As a result, this time- length was selected for further experiments.  
 
3.1.2 Method for purification 
	  
    Solid phase extraction (SPE) column was involved in the sample purification in order to protect the 
chromatographic column.  
The purification method was optimized and determined as follows:  
    Transfer 6 mL of the solution obtained in the sample extraction to a flask and add respective volume of 
water in order to obtain a mixture containing 20% methanol. Sonicate for 10 min to mix well. Condition the 
solid- phase extraction column containing C18 packaging with a sorbent mass- to- column volume ratio of 
200mg/4mL, before solvent application by washing the column with 3 mL 100% methanol and 5 mL pure 
water. Do not allow the column to dry.  
Transfer the sample solution to the SPE column and elute at the rate of 1 drop/s. Then wash the flask and the 
residue 3 times with 2 mL 20% aqueous solution of methanol and pass it trough the column. Subsequently 
perform a wash of the column with 3 mL pure water, discard the filtrate. Then elute the column with methanol 
and collect the eluent into a 2-mL volumetric flask, then shake well and pass through a filter having 0.22-µm 
porosity prior to use, discard about 0.5 mL of the first part of the filtrate. 
 
3.1.2.1 The function of SPE columns 
    As a result of the viscosity of the sample solution an increase of pressure throughout the chromatographic 
performance could be observed. The result of which was that the UHPLC chromatograph could be seriously 
damaged. The use of SPE- C18 columns facilitated the removal of some polar and nonpolar impurities from 
the sample solution. The discard of impurities could result in a smoother baseline in the recorded 
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chromatograms and protect the UHPLC chromatograph and the column, due to maintaining the pressure 
compatible to the instrument.   
 
3.1.2.2 Condition method for SPE columns 
    According to the guidelines of Alltech SPE column, 3- 5 mL of methanol and 3- 5 mL of water should be 
used to condition the column. 3 mL of methanol and 5 mL of water were selected for the further study.  
 
3.1.2.3 Application method for SPE columns 
	  
3.1.2.3.1 Selection of solvent for sample solution 
    The experiment investigated the sample solution used in application procedure of SPE.  
Perform as follows:  
    6 mL of the sample solution, obtained in the section 3.1 were transferred to a flask. Respective volumes of 
water were added in order to obtain o a mixture containing 10%, 15% and 20% methanol. 
    A 20% methanol solution was selected due to its attribution to a smooth baseline and reduction of impurities.   
3.1.2.3.2 Selection of application rate 
    The application process with 20% methanol as application solvent turned out to be very time consuming. In 
order to accelerate that procedure, the aid of an external force was needed. Compression was chosen and the 
rate of elution was controlled at 1 drop per second. No loss of analyte occurred at the selected rate of elution.  
  
3.2. Investigation of the chromatographic system 
	  
Optimized chromatographic system: 
Solution A: water 
Solution B: filtered and degassed acetonitrile  
Standard solution: 0.0572mg/mL of Rg1, 0.0353 mg/mL of Re, 0.0222mg/mL of Rf, 0.0531mg/mL of Rc, 
0.0247 mg/mL of Rd 
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Column: Agilent Bonus- FP C18 (2.1×100mm, 1.8µm; Part No. 828768-901; Serial No. USCCZ01170); 
Agilent 1290 Infinity In-Line Filter 
Mobile phase: See the gradient below. 
Time 
(minutes) 
A 
(%) 
B 
(%) 
0 82 18 
5 78 22 
7 72 28 
15 56 44 
23 0 100 
32 0 100 
Detector: UV, 203 nm 
Flow rate: 0.45 mL/min 
Injection size: 5 µL 
Column temperature: 40 °C 
Integration parameters: Slope sensitivity: 5; Peak width: 0.02; Baseline at Valleys 
 
 
3.2.1 Identification of the main peaks in the chromatogram of the sample solution 
	  
    Five major peaks appeared in the sample solution and in the standard solutions as shown in Figure II-3-2-1.  
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Figure II-3-2-1 main peaks in the sample solution vs. main peaks in the standard solutions (A: sample 
solution; B: Ginsenoside Rg1; C: Ginsenoside Re; D: Ginsenoside Rf; E: Ginsenoside Rc; F: Ginsenoside 
Rd 
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3.2.2 Determination of the wavelength of the detector 
	  
    Standard solutions were prepared and scanned in the entire UV range (190- 400 nm) to determine the λ max.  
Perform as follows:  
    Dissolve an appropriate quantity of ginsenosides Rg1, Re, Rf, Rc and Rd in methanol separately, and dilute 
to obtain the standard solutions with known concentrations. 
    All spectrum only showed an end absortion, thus the detection wavelength was fixed at 203nm (Figure III -
3-2-2) 
 
 
Ginsenoside Ginsenoside 
Rg1 Re 
  
Ginsenoside Ginsenoside 
Rf Rc 
  
Ginsenoside  
Rd  
 
 
 
Figure III -3-2-2 Spectrum of analytes 
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3.2.3 Selection of chromatographic column 
	  
    Five types of columns were tested with the sample solution, inclusive of Zobax Eclipse plus C18, Zobax 
Extend C18, Poroshell SB- C18, Zobax SB- C18 and Bonus- FP C18 shown in Figure IV-3-2-3. 
 
Figure IV-3-2-3 Selection of chromatographic column (A: Zobax Eclipse plus C18; B: Zobax Extend 
C18; C: Poroshell SB- C18; D: Zobax SB- C18; E: Bonus- FP C18) 
 
    The use of the column Bonus- FP C18 led to the best peak separation and resolution comparing to the other 
investigated columns. Using Bonus- FP C18 gave the ability to separate each of the target peaks. The use of 
the columns Eclipse, Extend, Poroshell and SB inhibited the separation of Rg1, Re and Rc, due to a mutual 
elution of Rg1 and Re and an elution of Rc together with a mix of other compounds.  
 
3.2.4 Selection of mobile phase 
	  
3.2.4.1 Selection of mobile phase system 
    Different mobile phase systems, mainly acetonitrile-acid water and acetonitrile-water were tested. 
Phosphoric acid was added into the water to improve separation quality, shown in Figure V-3-2-4-1.  
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Figure V-3-2-4-1 Selection of mobile phase system (A: acetonitrile-acid water; B: acetonitrile-water) 
    An unexpected following peak after Rd was recorded in the chromatogram when using acid water as mobile 
phase. However, no such a peak appeared when performing with water as a mobile phase. Considering this fact, 
water was selected as mobile phase in order to achieve a precise quantitative determination of Rd.   
 
3.2.4.2 Selection of the program of mobile phase 
    The experiment investigated the program of mobile phase shown in Table V-3-2-4-2 and Table VI-3-2-4-2.  
 
    Gradient elution (0/5/7/15/23/32 min, 18/22/28/44/100/100% acetonitrile) was involved in, considering the 
complexity of the sample solution. Elution program was divided into four sections. 
 
The peaks Rg1 and Re would be eluted in section 2.  
The peaks Rc, Rf and Rd would be eluted in section 3. 
Sections 4 and 5 would serve for a complete wash of the column in order to remove sample residues.  
 
    Investigations were performed focusing on these sections, including time and ratio of ACN. 
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Table V-3-2-4-2 Selection of the program of mobile phase 
Programs 
Original program (Original) 0/5/7/15/23/32min 18/22/28/44/100/100 % ACN 
The time length of 
different sections 
(A) 0/4/7/15/23/32min 18/22/28/44/100/100 % ACN 
(B) 0/6/7/15/23/32min 18/22/28/44/100/100 % ACN 
(C) 0/5/6/15/23/32min 18/22/28/44/100/100 % ACN 
(D) 0/5/8/15/23/32min 18/22/28/44/100/100 % ACN 
The ratio of ACN 
(A’) 0/5/7/15/23/32min 17/22/28/44/100/100 %  ACN 
(B’) 0/5/7/15/23/32min 19/22/28/44/100/100 % ACN 
(C’) 0/5/7/15/23/32min 18/21/28/44/100/100 % ACN 
(D’) 0/5/7/15/23/32min 18/23/28/44/100/100 % ACN 
(E’) 0/5/7/15/23/32min 18/22/27/44/100/100 % ACN 
(F’) 0/5/7/15/23/32min 18/22/29/44/100/100 % ACN 
(G’) 0/5/7/15/23/32min 18/22/28/43/100/100 % ACN 
(H’) 0/5/7/15/23/32min 18/22/28/45/100/100 % ACN 
  
 
Table VI-3-2-4-2 Resolution of the analytes and the corresponding preceding- peak 
 Original A B C D A’ B’ C’ D’ E F G H 
Rg1 2.78 2.44 2.76 2.39 2.55 3.25 2.83 4.52 4.61 2.58 2.54 2.59 2.58 
Re 2.02 1.66 1.91 1.62 1.82 1.78 1.86 1.81 1.78 1.83 1.78 1.79 1.77 
Rf 2.75 1.74 2.69 1.26 1.62 2.49 2.19 2.58 1.98 1.96 2.68 2.24 2.35 
Rc 1.74 1.36 1.45 1.45 0.92 1.50 1.46 1.50 1.43 1.43 1.48 1.41 1.45 
Rd 1.48 1.21 1.33 1.24 1.30 1.31 1.34 1.32 1.24 1.33 1.30 1.24 1.31 
 
    The best resolution of all target peaks was obtained by the following gradient: 0/5/7/15/23/32 min, 
18/22/28/44/100/100% acetonitrile.  
 
3.2.5 Selection of flow rate 
 
    The experiment investigated the impact of flow rate (0.40 mL/min, 0.45 mL/min, 0.50 mL/min) on the 
separation quality, shown in Figure VI-3-2-5 and Table VII-3-2-5.  
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Figure VI-3-2-5 Selection of flow rate (A: 0.40 mL/min; B: 0.45 mL/min; C: 0.50 mL/min) 
 
Table VII-3-2-5 Resolution between analytes and corresponding preceding- peaks 
Flow rate 0.4 mL/min 0.45 mL/min 0.5 mL/min 
Pressure 395 445 505 
Rg1 2.68 2.78 2.74 
Re 1.81 2.02 2.19 
Rf 3.54 2.75 2.50 
Rc 1.75 1.74 1.65 
Rd 1.66 1.74 3.50 
 
    With the use of a flow rate of 0.45 mL/min the best peak separation could be assessed among the 
investigated flow rates. In addition a flow rate of 0.5 mL/min caused a high pressure of 505 bar, which was not 
convenient for the applied column since it could undertake maximum 600 bar. 
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3.2.6 Selection of temperature 
 
    The experiment investigated the impact of temperature (35°, 40°, 45°) on the separation quality, shown in 
Figure VII-3-2-6 and Table VIII-3-2-6.  
 
Figure VII-3-2-6 Selection of temperature (A: 35°; B: 40°; C: 45°) 
 
Table VIII-3-2-6 Resolution between analytes and corresponding preceding- peaks 
Temperature 35° 40° 45° 
Rg1 2.78 2.30 1.59 
Re 2.02 1.92 1.74 
Rf 2.75 2.61 3.46 
Rc 1.74 1.87 2.04 
Rd 1.48 1.62 1.82 
 
    As the results show an increase of temperature from 35° to 45° led to a decrease of the resolution of Rg1 
and Re and an increase of the resolution of Rf, Rc and Rd. As a compromise 40° was selected as 
temperature for further investigations.  
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3.2.7 Selection of injection volume 
 
    The experiment investigated the impact of injection volume (3 µL, 5 µL, 7 µL) on the separation quality, 
shown in Figure VIII-3-2-7 and Table IX-3-2-7. 
 
Figure VIII-3-2-7 Selection of injection volume (A: 3 µL; B: 5 µL; C: 7 µL) 
 
Table IX-3-2-7 Resolution between analytes and corresponding preceding- peaks 
Injection volume 3µL 5µL 7µL 
Rg1 3.61 2.78 2.29 
Re 2.45 2.02 1.50 
Rf 2.78 2.75 2.47 
Rc 1.70 1.74 1.66 
Rd 5.52 1.48 1.48 
 
    The most appropriate peak area and peak shape among the investigated injection volumes could be obtained 
with 5 µL as injection volume. Using 3 µL as injection volume led to a too low peak area while 7 µL showed 
deformed peak shapes of Rg1 and Re. 
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3.3. Validation of method 
	  
    The method was validated in terms of precision, specificity, robustness, stability, linearity and accuracy. 
External standard method (ESM) was adopted. A standard mixture of five reference standards containing 
known concentrations of the analytes, were analyzed simultaneously to the sample solution.  The peak areas 
were recorded, respectively. The content of the components in the sample was calculated using the peak area 
data and concentration of the standard mixture.  
 
 
 
    Au and As represent the peak areas of Ginsenosides Rg1, Re, Rf, Rc and Rd, obtained from the sample 
solution and standard solution, respectively; Cu represents the concentration, in mg per mL, of Panax Ginseng 
Radix et Rhizoma Rubra in the sample solution; Cs is the concentration of Ginsenosides Rg1, Re, Rf, Rc and 
Rd in the standard solution, respectively.  
 
3.3.1 Accuracy 
	  
    Accuracy was carried out by calculating the percentage of recovery.  
Prepare sample solutions in three different amount levels (low, medium and high) and triplicate experiments at 
each level. Perform as follows:  
 
For low level: Transfer about 0.2 g of Red Ginseng powder, accurately weighed, to a 50-mL centrifuge tube. 
Respectively, add 19 mL of 70% aqueous solution of methanol and 1 mL of the stock standard solution 
(containing 0.2858 mg/mL Rg1, 0.1764 mg/mL Re, 0.1110 mg/mL Rf, 0.2656 mg/mL Rc, 0.1233 mg/mL Rd 
in 70% aqueous solution of methanol), then proceed as directed in the optimized sample preparation.  
For medium level: Transfer about 0.2 g of Red Ginseng powder, accurately weighed, to a 50-mL centrifuge 
tube. Respectively, add 18 mL of 70% aqueous solution of methanol and 2 mL of the stock standard solution 
and proceed as directed in the optimized sample preparation.  
For high level: Transfer about 0.2 g of Red Ginseng powder, accurately weighed, to a 50-mL centrifuge tube. 
Respectively, add 17 mL of 70% aqueous solution of methanol and 3 mL of the stock standard solution and 
proceed as directed in the optimized sample preparation.  
 
    The total amount of Ginsenosides Rg1, Re, Rf, Rc and Rd, found in 9 test solutions was calculated by the 
external standard method (ESM).  
Content (%) = (Au/As)*(Cs/Cu)*100 
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    The difference between obtained amount and original amount divided by spiked amount of Ginsenosides 
Rg1, Re, Rf, Rc and Rd, was used to calculate the recovery, shown in Table X-3-3-1 to Table XV-3-3-1.  
 
 
 
 
 
 
Table X-3-3-1 Recovery Test of Ginsenosides 
Analytes Level 
Found 
(µg) 
Spiked 
(µg) 
Original 
(µg) 
Recovery 
( %) 
RSD 
( %) 
Average 
( %) 
RSD 
( %) 
Rg1 
low level 791.9 
1086.5 
1367.0 
285.8 
571.6 
857.5 
484.5 
485.0 
485.1 
107.56 
105.22 
102.86 
0.75 
1.65 
0.53 
105.21 2.23 medium level 
high level 
Re 
low level 437.8 176.4 256.2 102.94 1.02 
103.02 1.11 medium level 624.1 352.8 256.4 104.20 1.81 
high level 795.8 529.3 256.5 101.91 0.65 
Rf 
low level 298.0 111.0 181.6 104.89 0.77 
104.23 1.06 medium level 414.5 222.0 181.8 104.85 1.73 
high level 524.6 333.0 181.8 102.95 0.64 
Rc 
low level 660.8 265.6 392.0 101.20 2.43 
99.83 1.49 medium level 923.8 531.2 392.3 100.04 2.16 
high level 1175.1 796.8 392.4 98.24 0.67 
Rd 
low level 333.2 123.3 204.5 104.35 0.25 
103.01 2.21 medium level 461.9 246.6 204.7 104.30 1.94 
high level 576.0 369.9 204.7 100.38 0.76 
 
 
 
 
 
 
 
 
Recovery (%) = (amount found- original amount)/amount spiked*100 
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Table XI-3-3-1 Recovery Test of Ginsenosides Rg1 
Level 
Found Spiked Original Recovery Average RSD Average RSD 
(µg) (µg) (µg) ( %) ( %) ( %) ( %) ( %) 
low 
792.8 285.8 484.4 107.88 
107.56 0.75 
105.21 2.23 
789.2 285.8 484.4 106.64 
793.8 285.8 484.7 108.15 
medium 
1075.9 571.6 484.9 103.38 
105.22 1.65 1096.0 571.6 485.4 106.82 
1087.5 571.6 484.7 105.45 
high 
1362.5 857.5 485.4 102.29 
102.86 0.53 1370.6 857.5 484.2 103.37 
1368.0 857.5 485.6 102.91 
 
 
Table XII-3-3-1 Recovery Test of Ginsenosides Re 
Level 
Found 
(µg) 
Spiked 
(µg) 
Original 
(µg) 
Recovery 
(%) 
Average 
( %) 
RSD 
( %) 
Average 
(%) 
RSD 
( %) 
low 
437.8 176.4 256.1 102.97 
102.94     1.02 
 
103.02 1.11 
435.9 176.4 256.1 101.88 
439.7 176.4 256.3 103.99 
medium 
618.0 352.8 256.4 102.49 
104.20 1.81 631.5 352.8 256.7 106.23 
622.8 352.8 256.3 103.89 
high 
792.0 529.3 256.7 101.15 
101.91 0.65 796.8 529.3 256.0 102.18 
798.7 529.3 256.8 102.39 
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Table XIII-3-3-1 Recovery Test of Ginsenosides Rf 
Level 
Found 
(µg) 
Spiked 
(µg) 
Original 
(µg) 
Recovery 
( %) 
Average 
( %) 
RSD 
( %) 
Average 
( %) 
RSD 
( %) 
low 
298.7 111.0 181.6 105.57 
104.89 0.77 
104.23 1.06 
297.0 111.0 181.6 103.99 
298.3 111.0 181.7 105.09 
medium 
411.3 222.0 181.7 103.41 
104.85 1.73 419.2 222.0 181.9 106.88 
413.1 222.0 181.7 104.24 
high 
522.6 333.0 181.9 102.30 
102.95 0.64 526.5 333.0 181.5 103.62 
524.8 333.0 182.0 102.93 
 
 
Table XIV-3-3-1 Recovery Test of Ginsenosides Rc 
Level 
Found Spiked Original Recovery Average RSD Average RSD 
(µg) (µg) (µg) (%) ( %) ( %) ( %) (%) 
low 
659.4 265.6 392.1 100.63 
101.20 2.43 
99.83 1.49 
655.0 265.6 391.9 99.07 
668.0 265.6 392.1 103.90 
medium 
914.7 531.2 392.3 98.34 
100.04 2.16 937.0 531.2 392.7 102.47 
919.6 531.2 392.1 99.31 
high 
1169.4 796.8 392.7 97.48 
98.24 0.67 1176.8 796.8 391.7 98.53 
1179.3 796.8 392.9 98.70 
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Table XV-3-3-1 Recovery Test of Ginsenosides Rd 
Level 
Found 
(µg) 
Spiked 
(µg) 
Original 
(µg) 
Recovery 
( %) 
Average 
( %) 
RSD 
( %) 
Average 
( %) 
RSD 
( %) 
low 
333.0 123.3 204.6 104.13 
104.35 0.25 
103.01 2.21 
333.0 123.3 204.4 104.29 
333.5 123.3 204.5 104.63 
medium 
457.7 246.6 204.6 102.63 
104.30 1.94 467.6 246.6 204.9 106.55 
460.3 246.6 204.5 103.73 
high 
573.6 369.9 204.9 99.69 
100.38 0.76 575.1 369.9 204.3 100.25 
579.3 369.9 205.0 101.21 
 
    The results of recovery for Rg1, Re, Rf, Rc and Rd were in the range of 102.29%-108.15% (RSD<3%), 
101.15%-106.23% (RSD<3%), 102.30%-106.88% (RSD<3%), 97.48%- 103.90% (RSD<3%), 99.69%-
106.55% (RSD<3%), respectively. The recovery (RSD<3%) met the requirements of the guidelines for the 
investigation and formulation of Chinese materia medica monographs in Chinese Pharmacopeia 2010.  
.  
 
3.3.2 Precision 
 
3.3.2.1 Repeatability 
    Repeatability was assessed using 9 sample solutions of the same Panax Ginseng Radix et Rhizoma Rubra 
covering three different concentration levels (low, medium and high). The experiments were triplicated at each 
level.  
 
Perform as follows: 
For low level: Transfer about 0.2 g of Red Ginseng powder, accurately weighed, to a 50-mL centrifuge tube 
and proceed as directed in the optimized sample preparation.  
For medium level: Transfer about 0.4 g of Red Ginseng powder, accurately weighed, to a 50-mL centrifuge 
tube and proceed as directed in the optimized sample preparation.  
For high level: Transfer about 0.6 g of Red Ginseng powder, accurately weighed, to a 50-mL centrifuge tube 
and proceed as directed in the optimized sample preparation.  
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Separately inject equal volumes (5 µL) of these prepared sample solutions into the UHPLC chromatograph, 
record the chromatograms and calculate the content, as shown in Table XVI-3-3-2-1.  
 
 
Table XVI-3-3-2-1 Repeatability of Ginsenosides 
Level Weight Rg1 Re Rf Rc Rd Total content Average RSD Average RSD 
  (g) (%) (%) (%) (%) (%) (%) (%) (%) (%) (%) 
low 
0.2 0.252 0.135 0.116 0.090 0.181 0.774 
0.775 0.80 
0.771 0.94 
0.2003 0.254 0.138 0.117 0.092 0.180 0.782 
0.1997 0.251 0.135 0.115 0.090 0.177 0.769 
medium 
0.3996 0.252 0.137 0.116 0.091 0.183 0.779 
0.771 1.25 0.4009 0.247 0.134 0.113 0.087 0.180 0.760 
0.4005 0.249 0.137 0.114 0.090 0.186 0.774 
high 
0.5997 0.247 0.136 0.113 0.089 0.182 0.766 
0.767 0.74 0.6001 0.250 0.136 0.115 0.090 0.182 0.773 
0.5992 0.246 0.134 0.113 0.088 0.181 0.762 
 
    The repeatability (RSD<2%) met the requirements of the guidelines for the investigation and formulation of 
Chinese materia medica monographs in Chinese Pharmacopeia 2010.  
 
 
 
3.3.2.2 Intermediate precision 
 
Different days 
 
    The test solutions were prepared in triplicate with the same Panax Ginseng Radix et Rhizoma Rubra 
everyday on three separate days.  
 
    Separately inject equal volumes (5 µL) of these prepared sample solutions into the UHPLC chromatograph, 
record the chromatograms and calculate the content, as shown in Table XVII-3-3-2-2. 
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Table XVII-3-3-2-2 Intermediate Precision of Ginsenosides- Different Days 
Day 
Rg1 Re Rf Rc Rd Total content Average RSD Average RSD 
(%) (%) (%) (%) (%) (%) (%) (%) (%) (%) 
1 
0.246 0.133 0.102 0.091 0.189 0.761 
0.760 0.89 
0.762 0.96 
0.247 0.135 0.103 0.092 0.190 0.767 
0.245 0.131 0.102 0.090 0.184 0.753 
2 
0.243 0.131 0.101 0.090 0.185 0.751 
0.762 1.30 0.248 0.135 0.104 0.092 0.191 0.769 
0.248 0.135 0.103 0.091 0.190 0.767 
3 
0.246 0.133 0.102 0.090 0.187 0.759 
0.762 1.08 0.248 0.136 0.104 0.092 0.192 0.772 
0.246 0.132 0.102 0.090 0.186 0.757 
 
    The Inter-day Precision (RSD<2%) met the requirements of the guidelines for the investigation and 
formulation of Chinese materia medica monographs in Chinese Pharmacopeia 2010.  
 
Different analysts 
 
    The test solutions were prepared independently by 3 operators, in triplicate with the same Panax Ginseng 
Radix et Rhizoma Rubra.  
 
    Separately inject equal volumes (5 µL) of these prepared sample solutions into the UHPLC chromatograph, 
record the chromatograms and calculate the content, as shown in Table XVIII-3-3-2-2. 
 
Table XVIII-3-3-2-2 Intermediate Precision of Ginsenosides- Different Analysts 
Analyst 
Rg1 Re Rf Rc Rd Total content Average RSD Average RSD 
(%) (%) (%) (%) (%) (%) (%) (%) (%) (%) 
1 
0.240 0.131 0.100 0.088 0.184 0.743 
0.751 0.99 
0.756 0.85 
0.245 0.133 0.102 0.090 0.187 0.757 
0.242 0.133 0.102 0.090 0.188 0.755 
2 
0.244 0.132 0.102 0.090 0.185 0.753 
0.755 0.27 0.245 0.133 0.102 0.090 0.187 0.757 
0.245 0.133 0.102 0.090 0.186 0.756 
3 
0.246 0.133 0.102 0.091 0.189 0.761 
0.760 0.89 0.247 0.135 0.103 0.092 0.190 0.767 
0.245 0.131 0.102 0.090 0.184 0.753 
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    The Inter-person Precision (RSD<2%) met the requirements of the guidelines for the investigation and 
formulation of Chinese materia medica monographs in Chinese Pharmacopeia 2010.  
 
 
3.3.3 Specificity 
 
    The specificity test was performed by separately injecting equal volumes (5 µL) of mixed standard solution, 
five standard compounds solutions, sample solution and solvent into the UHPLC chromatograph.   
 
   These solutions were analyzed and their chromatograms were recorded as shown in Figure IX-3-3-3 and 
Figure X-3-3-3.  
 
 
Figure IX-3-3-3 Specificity of Ginsenosides (A: standard solution; B: sample solution; C: solvent blank) 
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Figure X-3-3-3 Specificity of Ginsenosides (A: Ginsenoside Rg1; B: Ginsenoside Re; C: Ginsenoside Rf; 
D: Ginsenoside Rc; E: Ginsenoside Rd) 
 
    Five integration peaks in the chromatogram of the sample solution could be ascertained as Ginsenosides 
Rg1, Re, Rf, Rc and Rd, since these peaks were corresponding in time to the peaks in the chromatogram of the 
standard solution. No such peaks of that retention time appeared in the chromatogram of the solvent.   
 
   The result of the specificity test met the requirements of the guidelines for the investigation and formulation 
of Chinese materia medica monographs in Chinese Pharmacopeia 2010.  
 
 
 
3.3.4 Stability test 
 
    The stability of the sample solution was investigated. The stability test was carried out by comparing the 
peak areas of Ginsenosides Rg1, Re, Rf, Rc and Rd in the chromatograms of the same sample solution, after 
storing at room temperature for different duration (0, 1, 2, 4, 8, 12, 24 hours). Stability was evaluated by 
calculating the RSD of area obtained, as shown in Table XIX-3-3-4.  
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Table XIX-3-3-4 Stability of Ginsenosides 
Time 
(Hour) 
Rg1 
(Peak Area) 
Re 
(Peak Area) 
Rf 
(Peak Area) 
Rc 
(Peak Area) 
Rd 
(Peak Area) 
0 196.3 109.7 82.5 131.7 81.9 
1 196.0 109.6 79.3 131.2 81.9 
2 196.3 109.6 79.2 131.5 82.0 
4 195.8 109.2 78.8 131.0 81.7 
8 195.7 109.4 78.9 131.0 81.7 
12 195.7 108.9 78.9 130.9 81.0 
24 195.2 108.7 78.8 130.7 80.9 
RSD (%) 0.20 0.35 1.69 0.27 0.55 
 
    The analytes were found to be stable within 24 hours in the sample solution (RSD<2%).  
 
 
3.3.5 Linearity and range 
 
Standards stock solution:  Dissolve 14.84 mg of Rg1, 9.90 mg of Re, 5.55 mg of Rf, 13.28 mg of Rc and 6.53 
mg of Rd in a 50-mL volumetric flask with methanol and quantitatively dilute with methanol to volume in 
order to obtain a standard solution having a know concentration of 0.2858 mg/mL, 0.1764 mg/mL, 0.1110 
mg/mL, 0.2656 mg/mL and 0.1233 mg/mL, respectively.  
 
Standard solutions:  Quantitatively transfer 0.1, 0.25, 0.5, 1, 1.5, 2, 2.5 mL of standard stock solution to seven 
5-mL volumetric flasks, dilute with methanol to volume and mix well.  
 
    Separately inject equal volumes (5 µL) of standard solution into the UHPLC chromatograph, record the 
chromatograms and measure the peak areas of Ginsenosides Rg1, Re, Rf, Rc and Rd.  
 
    The calibration curve was constructed by plotting the peak area of each compound against the concentration 
of each compound.  
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Table XX-3-3-5 Calibration curve of Ginsenosides 
Analytes Regression equation R² Linearity range (µg/mL) Residual sum of squares 
Rg1 Y= 3201.27x-0.16 1.0000 5.72-142.91 6.19 
Re Y= 3339.63x-0.23 1.0000 3.53-88.21 2.97 
Rf Y= 3822.69x-0.54 0.9999 2.22-55.50 5.35 
Rc Y= 2601.27x+1.36 1.0000 5.31-132.80 2.14 
Rd Y= 3198.57x-0.09 1.0000 2.47-61.64 1.09 
 
 
 
 
 
 
 
 
Figure XI-3-3-5 Calibration curve of Ginsenosides 
 
    The results showed good linearity of Ginsenosides Rg1, Re, Rf, Rc, Rd in the range of 5.72-142.91 µg/mL, 
3.53-88.21 µg/mL, 2.22-55.50 µg/mL, 5.31-132.80 µg/mL and 2.47-61.64 µg/mL respectively.  
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3.3.6 Robustness 
 
    The robustness of the established method was evaluated by examining its stability with small variations of 
procedural parameters, inclusive of wavelength of UV- Visible detector, flow rate, injection volume, column 
temperature and program of mobile phase.   
 
    The chromatograms obtained from three injections of the standard solution were compared in terms of 
relative standard deviation of peak area, relative standard deviation of retention time, number of theoretical 
plates, resolution between our target compounds and the preceding peaks as well as content related to Rg1, Re, 
Rf, Rc and Rd. 
 
3.3.6.1 Wavelength of UV- Visible Detector 
 
    Different detection wavelengths (200 nm, 203 nm, 206 nm) were investigated with standard solution, shown 
in Table XXI-3-3-6-1. Content determination of sample solution was also performed, shown in Table XXII-3-
3-6-1.  
 
Table XXI-3-3-6-1 Robustness- Wavelength of UV- Visible Detector 
Wavelength 
(nm) 
Ginsenosides 
RSD of Retention 
time (%) 
RSD of Peak 
area (%) 
Symmetry 
Number of theoretical 
plates 
200 
 
Rg1 0.20 0.03 0.87 7.44E+04 
Re 0.22 0.35 0.84 9.96E+04 
Rf 0.00 0.06 0.84 2.37E+05 
Rc 0.09 0.04 0.93 3.27E+05 
Rd 0.09 0.14 0.88 3.68E+05 
203 
 
Rg1 0.20 0.11 0.87 7.44E+04 
Re 0.22 0.29 0.84 9.96E+04 
Rf 0.00 0.08 0.84 2.35E+05 
Rc 0.09 0.66 0.93 3.27E+05 
Rd 0.09 0.00 0.88 3.68E+05 
206 
Rg1 0.20 0.10 0.87 7.44E+04 
Re 0.22 0.24 0.84 9.96E+04 
Rf 0.00 0.00 0.84 2.37E+05 
Rc 0.09 1.05 0.94 3.27E+05 
Rd 0.09 0.13 0.88 3.68E+05 
Panax	  Ginseng	  Radix	  et	  Rhizoma	  Rubra	  
38	  
	  
Table XXII-3-3-6-1 Robustness- Wavelength of UV- Visible Detector 
Wavelength Ginsenosides Resolution Content Total content Average RSD 
(nm)     (%) (%) (%) (%) 
200 
Rg1 2.70 0.24 
0.77 
0.77 0.12 
Re 2.06 0.13 
Rf 3.11 0.09 
Rc 1.86 0.20 
Rd 1.59 0.10 
203 
Rg1 2.70 0.24 
0.77 
Re 2.06 0.13 
Rf 2.94 0.09 
Rc 1.86 0.20 
Rd 1.59 0.10 
206 
Rg1 2.69 0.24 
0.77 
Re 2.06 0.13 
Rf 2.91 0.09 
Rc 1.86 0.20 
Rd 3.53 0.10 
     
The results showed that a wavelength error of ±3 nm caused by instruments would have no significant effect 
on the content determination (RSD>2%). The results obtained from the suitability test met the requirements. 
Thus a wavelength error in the range of ±3 nm would have no impact on the determination. 
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3.3.6.2 Flow rate 
 
    Different flow rates of mobile phase (0.40 mL/min, 0.45 mL/min, 0.50 mL/min) were investigated with 
standard solution, shown in Table XXIII-3-3-6-2. Content determination of sample solution was also 
performed, shown in Table XXIV-3-3-6-2.  
 
 
Table XXIII-3-3-6-2 Robustness- Flow rate 
Flow rate 
(mL/min) 
Ginsenosides 
RSD of Retention time 
(%) 
RSD of Peak area 
(%) 
Symmetry 
Number of theoretical 
plates 
0.4 
Rg1 0.22 0.03 0.90 8.38E+04 
Re 0.20 0.05 0.85 1.08E+05 
Rf 0.14 1.03 0.86 2.19E+05 
Rc 0.12 0.05 0.95 3.02E+05 
Rd 0.06 1.20 0.90 3.38E+05 
0.45 
Rg1 0.20 0.11 0.87 7.44E+04 
Re 0.22 0.29 0.84 9.96E+04 
Rf 0.00 0.08 0.84 2.35E+05 
Rc 0.09 0.66 0.93 3.27E+05 
Rd 0.09 0.00 0.88 3.68E+05 
0.50 
 
Rg1 0.80 0.00 0.96 6.02E+04 
Re 0.65 0.00 0.92 8.15E+04 
Rf 0.21 0.18 0.91 2.04E+05 
Rc 0.08 0.79 1.01 2.85E+05 
Rd 0.05 0.40 1.01 3.18E+05 
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Table XXIV-3-3-6-2 Robustness- Flow rate 
Flow rate 
(mL/min) 
Ginsenosides Resolution 
Content 
(%) 
Total content 
(%) 
Average 
(%) 
RSD 
(%) 
0.40 
Rg1 2.42 0.24 
0.76 
 
0.76 
 
0.47 
 
Re 1.85 0.13 
Rf 3.11 0.08 
Rc 1.86 0.21 
Rd 1.67 0.10 
0.45 
Rg1 2.70 0.24 
0.76 
 
Re 2.06 0.13 
Rf 2.94 0.09 
Rc 1.86 0.20 
Rd 1.59 0.10 
0.50 
 
Rg1 2.57 0.24 
0.76 
 
Re 2.09 0.13 
Rf 2.28 0.09 
Rc 1.67 0.20 
Rd 4.61 0.10 
 
    The results showed that a flow rate of 0.50 mL/min had a significant influence on the resolution between Rd 
and its preceding peak. A flow rate of 0.40 mL/min showed no significant influence on the resolution of Rd 
and its preceding peak. However, other parameters were only slightly changed. All parameters, related to the 
suitability test, met the requirements. The results showed that a flow rate variation of ±0.05 mL/min would 
have no significant effect on the content determination (RSD<1%). Thus a flow rate variation in the range of 
±0.05 mL/min was acceptable.  
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3.3.6.3 Injection volume 
 
    Different injection volumes (1 µL, 3 µL, 5 µL) were investigated with standard solution, shown in Table 
XXV-3-3-6-3. Content determination of sample solution was also performed, shown in Table XXVI-3-3-6-3.  
 
 
Table XXV-3-3-6-3 Robustness- Injection Volume 
Injection 
volume 
(µL) 
Ginsenosides 
RSD of Retention 
time (%) 
RSD of Peak 
area (%) 
Symmetry 
Number of theoretical 
plates 
1 
Rg1 0.20 3.33 1.04 6.34E+04 
Re 0.17 12.12 0.89 7.98E+04 
Rf 0.09 2.97 1.08 1.74E+05 
Rc 0.08 0.00 1.00 2.46E+05 
Rd 0.02 3.01 0.98 2.58E+05 
3 
Rg1 0.13 0.51 1.00 6.16E+04 
Re 0.12 0.88 0.96 7.97E+04 
Rf 0.07 1.67 0.99 1.63E+05 
Rc 0.04 0.60 1.01 2.34E+05 
Rd 0.02 0.00 0.98 2.61E+05 
5 
 
Rg1 0.20 0.11 0.87 7.44E+04 
Re 0.22 0.29 0.84 9.96E+04 
Rf 0.00 0.08 0.84 2.35E+05 
Rc 0.09 0.66 0.93 3.27E+05 
Rd 0.09 0.00 0.88 3.68E+05 
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Table XXVI-3-3-6-3 Robustness- Injection Volume 
Injection 
volume Ginsenosides Resolution Content Total content Average RSD 
(µL)     (%) (%) (%) (%) 
1 
Rg1 2.80 0.25 
0.77 
0.76 0.26 
Re 2.13 0.14 
Rf 29.11 0.09 
Rc 1.66 0.19 
Rd 3.08 0.10 
3 
Rg1 2.73 0.25 
0.77 
Re 2.10 0.13 
Rf 2.31 0.09 
Rc 1.63 0.20 
Rd 2.80 0.10 
5 
Rg1 2.70 0.24 
0.76 
Re 2.06 0.13 
Rf 2.94 0.09 
Rc 1.86 0.20 
Rd 1.59 0.10 
 
    The results showed that a decrease of injection volume to 1 µL had a significant influence on the resolution 
of Rf and Rd and the preceding peaks, while an injection volume of 3 µL showed no impact on their resolution. 
Due to the high RSD of peak area obtained from 1 µL as injection volume, the parameter was not acceptable.    
All other parameters, related to the suitability test, met the requirements. Regarding the content determination 
(RSD<1%) no significant influence was notable. Thus, a decrease of injection volume from 5 µL to 3 µL was 
acceptable. 
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3.3.6.4 Column temperature 
 
    Different column temperatures (35°, 40°, 45°) were investigated with standard solution, shown in Table 
XXVII-3-3-6-4. Content determination of sample solution was also performed, shown in Table XXVIII-3-3-6-
4.  
 
Table XXVII-3-3-6-4 Robustness- Column temperature 
Column 
Temperature 
(°) 
Ginsenosides 
RSD of Retention 
time (%) 
RSD of Peak 
area (%) 
Symmetry 
Number of 
theoretical plates 
35 
Rg1 2.10 0.19 0.94 9.49E+04 
Re 1.90 2.23 0.89 1.23E+05 
Rf 1.09 0.42 0.97 2.01E+05 
Rc 0.76 0.10 1.03 2.70E+05 
Rd 0.49 1.53 1.00 3.01E+05 
40 
Rg1 0.20 0.11 0.87 7.44E+04 
Re 0.22 0.29 0.84 9.96E+04 
Rf 0.00 0.08 0.84 2.35E+05 
Rc 0.09 0.66 0.93 3.27E+05 
Rd 0.09 0.00 0.88 3.68E+05 
45 
 
Rg1 0.29 0.27 0.98 5.84E+04 
Re 0.29 0.35 0.94 7.69E+04 
Rf 0.09 0.42 0.94 1.82E+05 
Rc 0.04 0.05 1.02 2.59E+05 
Rd 0.04 1.08 1.00 2.92E+05 
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Table XXVIII-3-3-6-4 Robustness- Column temperature 
Column 
Temperature (°) 
Ginsenosides Resolution 
Content 
(%) 
Total content 
(%) 
Average 
(%) 
RSD 
(%) 
35 
Rg1 2.98 0.24 
0.76 
0.76 
 
0.37 
 
Re 2.02 0.13 
Rf 2.45 0.09 
Rc 1.61 0.20 
Rd 2.17 0.10 
40 
Rg1 2.70 0.24 
0.76 
 
Re 2.06 0.13 
Rf 2.94 0.09 
Rc 1.86 0.20 
Rd 1.59 0.10 
45 
 
Rg1 1.91 0.24 
0.77 
 
Re 1.72 0.13 
Rf 2.12 0.09 
Rc 1.77 0.20 
Rd 1.58 0.10 
 
    The results showed that the column temperature had notable influence on the resolution of almost all 
components and the preceding peak. Due to the high RSD of peak area and retention time obtained from 35° as 
column temperature, the parameter was not acceptable. All other parameters, related to the suitability test, met 
the requirements. Regarding the content determination (RSD<1%), no significant influence was notable. Thus, 
the variation of column temperature, from 40° to 45° was acceptable.  
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3.3.6.5 Program of mobile phase 
 
3.3.6.5.1 Time points of gradient elution 
    Three mobile phase programs, involving the gradient elution (0/5/7/15/23/32 min, 18/22/28/44/100/100 % 
acetonitrile) were tested, by adding or cutting 1 minute, shown in Table XXIX-3-3-6-5-1. Content 
determination of sample solution was also performed, shown in Table XXX-3-3-6-5-1.  
 
 
Table XXIX-3-3-6-5-1 Robustness- Program of mobile phase 
Time 
points 
(min) 
Ginsenosides 
RSD of Retention 
time (%) 
RSD of Peak 
area (%) 
Symmetry 
Number of theoretical 
plates 
4/6/14 
Rg1 0.00 0.08 0.87 8.62E+04 
Re 0.06 0.18 0.83 1.02E+05 
Rf 0.10 0.42 0.85 1.88E+05 
Rc 0.04 0.51 0.94 2.59E+05 
Rd 0.03 0.63 0.90 3.00E+05 
5/7/15 
Rg1 0.20 0.11 0.87 7.44E+04 
Re 0.22 0.29 0.84 9.96E+04 
Rf 0.00 0.08 0.84 2.35E+05 
Rc 0.09 0.66 0.93 3.27E+05 
Rd 0.09 0.00 0.88 3.68E+05 
6/8/16 
 
Rg1 0.12 0.15 0.92 4.30E+04 
Re 0.11 0.06 0.88 7.16E+04 
Rf 0.06 0.08 0.86 2.58E+05 
Rc 0.02 0.15 0.95 3.66E+05 
Rd 0.02 0.09 0.92 4.07E+05 
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Table XXX-3-3-6-5-1 Robustness- Program of mobile phase 
Time points (min) Ginsenosides Resolution 
Content 
(%) 
Total content 
(%) 
Average 
(%) 
RSD 
(%) 
4/6/14 
Rg1 2.23 0.24 
0.76 
0.76 0.41 
Re 1.73 0.13 
Rf 2.76 0.09 
Rc 1.85 0.20 
Rd 1.55 0.10 
5/7/15 
Rg1 2.70 0.24 
0.76 
Re 2.06 0.13 
Rf 2.94 0.09 
Rc 1.86 0.20 
Rd 1.59 0.10 
6/8/16 
 
Rg1 2.88 0.24 
0.76 
Re 2.27 0.13 
Rf 2.82 0.09 
Rc 1.79 0.20 
Rd 1.55 0.10 
 
    The results showed that a variation of time points had notable influence on the resolution of almost all 
components and the preceding peak. However, other parameters were only slightly changed. All parameters, 
related to the suitability test, met the requirements. Regarding the content determination (RSD<1%), no 
significant influenced was notable. Thus, a variation of time points in the range of ±1 minute was acceptable.  
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3.3.6.5.2 ACN ratio of gradient elution 
 
    Three mobile phase programs, involving the gradient elution (0/5/7/15/23/32 min, 18/22/28/44/100/100 % 
acetonitrile) were tested by adding or cutting 1 % of ACN shown in Table XXXI-3-3-6-5-2. Content 
determination of sample solution was also performed, shown in Table XXXII-3-3-6-5-2.  
 
 
Table XXXI-3-3-6-5-2 Robustness- Program of mobile phase 
Ratio of 
ACN 
(%) 
Ginsenosides 
RSD of Retention 
time (%) 
RSD of Peak 
area   (%) 
Symmetry 
Number of theoretical 
plates 
21/27/43 
Rg1 0.17 0.34 1.01 1.01E+05 
Re 0.13 0.48 0.94 1.26E+05 
Rf 0.03 0.58 1.01 1.73E+05 
Rc 0.02 0.30 1.07 2.43E+05 
Rd 0.00 1.41 1.06 2.67E+05 
22/28/44 
Rg1 0.20 0.11 0.87 7.44E+04 
Re 0.22 0.29 0.84 9.96E+04 
Rf 0.00 0.08 0.84 2.35E+05 
Rc 0.09 0.66 0.93 3.27E+05 
Rd 0.09 0.00 0.88 3.68E+05 
23/29/45 
 
Rg1 0.95 0.08 1.02 2.26E+04 
Re 0.87 0.47 1.00 2.73E+04 
Rf 0.10 0.33 1.03 1.40E+05 
Rc 0.05 0.00 1.07 1.96E+05 
Rd 0.04 0.99 1.11 2.13E+05 
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Table XXXII-3-3-6-5-2 Robustness- Program of mobile phase 
Ratio of ACN 
(%) 
Ginsenosides Resolution 
Content 
(%) 
Total content 
(%) 
Average 
(%) 
RSD 
(%) 
21/27/43 
Rg1 2.15 0.24 
0.75 
0.76 0.79 
Re 1.67 0.13 
Rf 2.36 0.09 
Rc 1.58 0.20 
Rd 1.42 0.10 
22/28/44 
Rg1 2.70 0.24 
0.76 
Re 2.06 0.13 
Rf 2.94 0.09 
Rc 1.86 0.20 
Rd 1.59 0.10 
23/29/45 
 
Rg1 1.83 0.24 
0.75 
Re 1.67 0.13 
Rf 2.16 0.09 
Rc 1.56 0.20 
Rd 1.44 0.10 
 
    The results showed that a variation of ACN proportion had notable influence on the resolution of almost all 
components and the preceding peak. However, other parameters were only slightly changed. All parameters, 
related to the suitability test, met the requirements. Regarding the content determination (RSD<1%), no 
significant influence could be observed. Thus, a variation of ACN proportion in the range of ±1 % was 
acceptable.  
 
    In conclusion a wavelength error in the range of ±3 nm would have no impact on the determination. The 
flow rate and program of mobile phase can be slightly adjusted for system suitability. Regarding the injection 
volume a decrease from 5 µL to 3 µL is acceptable. The column temperature can be increased to 45°.  
 
    Based on the robustness tests, system suitability parameters are specified as follows: symmetry in the range 
of 0.5 to 1.5; relative standard deviation: NMT 2.0%; resolution: NLT 1.5; number of theoretical plates: NLT: 
20000.  
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4. Content of different batches of Panax Ginseng Radix et Rhizoma Rubra 
	  
    Sample solutions of 4 batches of commercial Panax Ginseng Radix et Rhizoma Rubra were determined 
using the validated method for Ginsenosides Rg1, Re, Rf, Rc and Rd, as shown in Table XXXIII-3-4.   
 
 
Table XXXIII-3-4 Content of 4 different batches of Panax Ginseng Radix et Rhizoma Rubra 
No. Origin Year Rg1 (%) Re (%) Rf (%) Rc (%) Rd (%) Total content (%) 
1 Fusong, China 6 0.24 0.13 0.09 0.20 0.10 0.76 
2 Fusong, China 5 0.39 0.20 0.10 0.36 0.17 1.23 
3 Fusong, China 4 0.42 0.23 0.12 0.32 0.15 1.24 
4 Ji-an, China 6 0.49 0.23 0.16 0.34 0.09 1.32 
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5. Summary 
	  
The root and rhizome of Red Ginseng (Panax Ginseng Radix et Rhizoma Rubra) represents a highly esteemed 
remedy in traditional Chinese medicine (TCM). Due to its replenishing properties it has been used as a tonic, 
since ancient times. Gradually it became established as a promising drug against numerous diseases, providing 
not only myriads of beneficial effects on central nerve, cardiovascular, endocrine and immune system, but also 
proving antineoplastic and immunmodulatory activity, reported in various studies.  
    Red Ginseng is generated from white ginseng (Panax Ginseng Radix et Rhizoma) through further processing. 
While white ginseng is obtained from fresh ginseng after sun- drying, Red Ginseng has to undergo an 
additional steaming step, followed by drying.  
    Extensive literature points out the decisive role of ginsenosides, which represent steroidal saponins, to which 
most of the beneficial effects of Red Ginseng are attributed. Among the ginsenosides contained in Red 
Ginseng, the ginsenosides Rg1, Re, Rf, Rc and Rd represent the major components due to their relatively high 
content.  
    Numerous studies on the simultaneous determination and quantification of multiple ginsenosides in various 
types of ginseng samples have been performed and developed.  However, ginsenosides could not be fully 
separated due to their very similar structures with the result that the amount of each ginsenoside could not be 
determined precisely.  
    The objective of the present diploma thesis was the development of an UHPLC- DAD method in order to 
simultaneously determine five major ginsenosides (Rg1, Re, Rf, Rc and Rd) in Red Ginseng, regarding a rapid, 
accurate and precise quantification.   
    Sonication and solid phase extraction (SPE) were applied to the sample preparation and the chromatography 
was performed on Agilent Bonus- FP C18 column involving a gradient elution with acetonitrile/water as the 
mobile phase.  
    The sample preparation was investigated regarding extraction solvent, extraction solvent volume, sonication 
frequency and time- length of sonication. In consideration of convenience and efficiency, an extraction method 
was developed comprising 40 mL 70% aqueous solution of methanol as extraction solvent and a sonication 
time-length of 15 min, repeated twice.  
    In addition the sample solution was purificated with the use of a SPE column prior to the chromatographic 
analysis, in order to discard impurities, which would seriously damage the applied column and prevent the 
assessment of stable results in the recorded chromatograms.  
    Furthermore various chromatographic parameters were studied and optimized in order to improve the 
sensitivity, resolution and baseline separation of the ginsenosides. 
    The amounts of the five ginsenosides were determined on the basis of external standard method.  
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    The method validation was performed according to the method performance requirements, inclusive of 
precision, recovery, specifity, stability, linearity and robustness.   
    In this diploma thesis a convenient and practicable method could be established, to simultaneously 
determine five ginsenosides in Red Ginseng.  
The developed method provides a high selectivity, linearity and robustness regarding the quantitative 
evaluation of five ginsenosides and can serve as a basis for the quality control of Red Ginseng.  
    However, further investigations could be performed on sample materials of different origin and age in order 
to determine the variation in the ginsenoside profile of cultivates ginseng landraces in Asia. 
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6. Zusammenfassung 
	  
    Die Wurzel und das Rhizom von Rotem Ginseng (Panax Ginseng Radix et Rhizoma Rubra) gelten als sehr 
geschätztes und angesehenes Heilmittel in der traditionellen Chinesischen Medizin. Aufgrund seiner 
regenerierenden Eigenschaften wurde Roter Ginseng bereits in der Vergangenheit als Tonikum eingesetzt. Im 
Laufe der Zeit hat sich die vielversprechende Arzneidroge gegen zahlreiche Krankheiten bewährt.  Zahlreiche 
Studien belegen nicht nur eine positive Auswirkung der Arzneidroge auf das Zentralnerven-, Kardiovaskuläre-, 
Endokrine- und Immun- System, sondern weisen auch auf eine antineoplastische und immunmodulatorische 
Aktivität hin.  
    Roter Ginseng stellt eine verarbeitete Form von weißem Ginseng dar (Panax Ginseng Radix et Rhizoma). 
Weißer Ginseng wird aus frischem Ginseng gewonnen, der in der Sonne getrocknet wird.  Roter Ginseng wird 
zusätzlich einem Dünstungsprozess unterzogen, gefolgt von einer Trocknung.  
    Umfassende Literatur deutet auf die entscheidende Rolle von Ginsenosiden, steroidale Saponine, hin, auf die 
zahlreiche positive Auswirkungen des Roten Ginsengs zurückzuführen sind.   
    Aufgrund ihres relativ hohen Anteils stellen die Ginsenoside Rg1, Re, Rf, Rc und Rd die 
Hauptkomponenten der enthaltenen Ginsenosiden dar.  
    Bisher wurden zahlreiche Studien hinsichtlich einer simultanen Bestimmung und Quantifizierung multipler 
Ginsenoside anhand von verschiedenen Proben durchgeführt und entwickelt. Da Ginsenoside einen sehr 
ähnlichen strukturellen Aufbau aufweisen, blieb eine simultane Bestimmung ohne Erfolg.  
    Das Ziel der vorliegenden Diplomarbeit war es eine geeignete UHPLC- DAD Methode zu entwickeln um 
eine simultane Bestimmung im Bezug auf eine schnelle, exakte und präzise Quantifizierung von fünf 
Ginsenosiden (Rg1, Re, Rf, Rc und Rd) zu ermöglichen.     
    Die Probenaufarbeitung erfolgte mithilfe von Ultraschall und einer Festphasenextraktion. Die 
chromatographische Analyse wurde basierend auf einer Agilent Bonus- FP C 18 Säule durchgeführt und 
beinhaltete eine Gradienteneluierung mit Acetonitril und Wasser als mobile Phase.  
    Die Probenaufarbeitung wurde hinsichtlich des Volumens und der Art des Extraktionsmittels, der 
Extraktionsdauer und der Extraktionshäufigkeit untersucht. Unter Berücksichtigung von Zweckmäßigkeit und 
Effizienz wurde eine Extraktionsmethode entwickelt, die 40 mL 70% wässrige Methanol Lösung als 
Exraktionsmittel beinhaltete, bei einer Extraktionsdauer von zweimal 15 Minuten.  
    Im Weiteren erfolgte vor der chromatographischen Analyse eine Probenaufreinigung mithilfe einer  
Vorsäule (Festphasenextraktionssäule), mit dem Ziel Schwankungen in der Werteerhebung zu vermeiden und 
Verunreinigungen aus der Probenlösung zu entfernen, die die Trennsäule beschädigen könnten.      
    Die Optimierung erfolgte hinsichtlich einer besseren Empfindlichkeit, Auflösung und Basislinientrennung in 
den aufgezeichneten Chromatogrammen.  
    Die Quantifizierung der fünf Ginsenoside erfolgte anhand eines externen Standards.   
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    Die Methodenvalidierung wurde gemäß der Anforderungen auf Präzision, Recovery, Spezifität, Stabilität, 
Linearität und Robustheit durchgeführt.  
    In der vorliegenden Diplomarbeit konnte eine praktische und geeignete Methode etabliert werden, die es 
erlaubt fünf Ginsenoside in Rotem Ginseng simultan nachzuweisen und zu bestimmen.  
Die entwickelte Methode bietet eine hohe Selektivität, Linearität und “Alltagstauglichkeit” im Bezug auf die 
quantitative Auswertung der fünf Ginsenoside und kann zudem als Basis für die Qualitätskontrolle von Rotem 
Ginseng angesehen werden.   
    Es bedarf jedoch weiteren Untersuchungen anhand von Probenmaterial verschiedenen Alters und Herkunft 
um eine Zuordnung zwischen der Ginsenosidzusammensetzung und verschiedener Ginseng- Landrassen in 
Asien zu ermöglichen.  
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